Core Vista Health has developed the CorVista System®, a groundbreaking point-of-care diagnostic platform designed to evaluate significant coronary artery disease (CAD) and pulmonary hypertension (PH) in a single visit. This innovative system leverages advanced machine learning algorithms to analyze a patient's cardiac and hemodynamic signals non-invasively, providing rapid and accurate results without the need for radiation, contrast agents, or invasive procedures. The CorVista System aims to enhance the efficiency of cardiovascular diagnostics, allowing healthcare providers to deliver timely and actionable insights that can significantly improve patient outcomes.

The CorVista System is particularly beneficial in addressing the challenges faced by patients in underserved areas, where access to specialized cardiac care may be limited. By enabling immediate access to high-quality cardiovascular diagnostics, the system supports healthcare professionals in making informed treatment decisions during the initial patient encounter. This approach not only reduces the time to diagnosis—often taking years for certain conditions—but also minimizes the need for follow-up appointments and specialist referrals, ultimately transforming the standard of care in cardiovascular health.

Canada

CorVista Health is transforming cardiovascular care with the CorVista System, a non-invasive point-of-care diagnostic technology, that shortens the path from symptoms to diagnosis, empowering earlier treatment and better patient outcomes. The CorVista System leverages proprietary machine-learned algorithms and robust clinical data to deliver results providers can trust. For more information visit www.corvista.com

Core Vista Health

Company Details